| # | Drug | Count |
|---|---|---|
| 0 | ENTECAVIR | 5 |
| 1 | ENTECAVIR ANHYDROUS | 5 |
| 2 | FAMOTIDINE | 4 |
| 3 | LAMIVUDINE | 4 |
| 4 | LAMIVUDINE ORAL | 4 |
| 5 | CANDESARTAN | 3 |
| 6 | SENNA LEAF | 3 |
| 7 | TRIAZOLAM | 3 |
| 8 | ACETAMINOPHEN | 2 |
| 9 | ACETAMINOPHEN 500MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND SODIUM ACETATE ANHYDROUS | 1 | 0.0286 |
| 1 | ADEFOVIR DIPIVOXIL | 2 | 0.0016 |
| 2 | TRIAZOLAM | 3 | 0.0007 |
| 3 | ENTECAVIR | 5 | 0.0004 |
| 4 | GEMFIBROZIL | 2 | 0.0002 |
| 5 | LAMIVUDINE | 4 | 0.0002 |
| 6 | SENNA LEAF | 3 | 0.0001 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 8 | EFAVIRENZ | 1 | 0.0001 |
| 9 | CANDESARTAN | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0002 |
| 1 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0000 |
| 4 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 2 | 0.0000 |
| 5 | Histamine-2 Receptor Antagonist [EPC] | 4 | 0.0000 |
| 6 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 1 | 0.0000 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Purine Antimetabolite [EPC] | 1 | 0.0000 |